Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 19, 2011 08:00 ET | Source: Icagen, Inc.

Icagen to Present at the Antiepileptic Drug Trials XI Conference

RESEARCH TRIANGLE PARK, N.C., April 19, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that management will participate in the Antiepileptic Drug Trials XI Conference to be held...
March 07, 2011 08:00 ET | Source: Icagen, Inc.

Icagen Reports Fourth Quarter and Full Year 2010 Financial Results and Operational Highlights

RESEARCH TRIANGLE PARK, N.C., March 7, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the fourth quarter and full year ended...
February 23, 2011 08:00 ET | Source: Icagen, Inc.

Icagen to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on March 7, 2011

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release financial results for the fourth quarter and full year 2010 on Monday, March...
February 03, 2011 08:30 ET | Source: Icagen, Inc.

Icagen to Present at the 13th Annual BIO CEO & Investor Conference on February 15, 2011

RESEARCH TRIANGLE PARK, N.C., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 13th Annual BIO CEO and Investor Conference...
February 02, 2011 08:15 ET | Source: Icagen, Inc.

Icagen Announces Lifting of Clinical Hold of ICA-105665

RESEARCH TRIANGLE PARK, N.C., Feb. 2, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that, following a review of data from recently completed clinical studies as well as the...
December 20, 2010 16:50 ET | Source: Icagen, Inc.

Icagen Announces Management Changes

RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that Seth V. Hetherington, M.D., SVP, Clinical and Regulatory Affairs, will be leaving the...
December 20, 2010 08:00 ET | Source: Icagen, Inc.

Icagen and Pfizer Initiate Phase I Trial in Nav1.7 Program

RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders, which is being...
November 30, 2010 08:30 ET | Source: Icagen, Inc.

Icagen and Pfizer Select Compound for Advancement in Nav1.7 Program

RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders which is being...
November 09, 2010 08:30 ET | Source: Icagen, Inc.

Icagen Reports Third Quarter 2010 Financial Results and Operational Highlights

RESEARCH TRIANGLE PARK, N.C., Nov. 9, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the third quarter ended September 30,...
November 02, 2010 08:30 ET | Source: Icagen, Inc.

Icagen Announces Receipt of Three Federal Government Grants

RESEARCH TRIANGLE PARK, N.C., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that it has been awarded approximately $733,000 of federal government grants under the...